Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Return on Assets [ROA] (2011 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) posted Return on Assets [ROA] of -21.01% for Q2 2026, up 24.24 percentage points from -45.24% a year earlier but down 10.33 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Lexicon Pharmaceuticals' Return on Assets [ROA] came in at -20.24%, up 54.45 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -1.39 percentage points (FY2020 to FY2025).
  • In prior years, Lexicon Pharmaceuticals' Return on Assets [ROA] was -74.69% in FY2024 (+6.38 pp), -81.07% in FY2023 (-18.54 pp), -62.52% in FY2022 (-11.01 pp) and -51.52% in FY2021 (-32.67 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -78.03% in Q2 2022 to a high of -10.68% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last five quarters, with an average year-over-year change of +18.59 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2026, with a gain of 48.87 percentage points; the weakest was Q2 2022, with a drop of 98.85 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -10.68% (Q1 2026), -25.02% (Q4 2025) and -30.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -21.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.01%
Mar 31, 2026 -10.68%
Dec 31, 2025 -25.02%
Sep 30, 2025 -30.99%
Jun 30, 2025 -45.24%
Mar 31, 2025 -59.54%
Dec 31, 2024 -63.63%
Sep 30, 2024 -60.80%
Jun 30, 2024 -50.84%
Mar 31, 2024 -59.32%
Dec 31, 2023 -70.93%
Sep 30, 2023 -55.32%
Jun 30, 2023 -56.11%
Mar 31, 2023 -63.31%
Dec 31, 2022 -53.65%
Sep 30, 2022 -64.33%
Jun 30, 2022 -78.03%
Mar 31, 2022 -66.19%
Dec 31, 2021 -56.84%
Sep 30, 2021 -39.40%
API Access

Lexicon Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LXRX&period=max&api_key=YOUR_API_KEY